Change Language
Call_us
Axe-250 Tablets (Cefuroxime Axetil Tablets IP 250 MG)

Axe-250 Tablets (Cefuroxime Axetil Tablets IP 250 MG)

168 INR/Box

Product Details:

X

Axe-250 Tablets (Cefuroxime Axetil Tablets IP 250 MG) Price And Quantity

  • 168 INR/Box
  • 100 , , Box

Axe-250 Tablets (Cefuroxime Axetil Tablets IP 250 MG) Trade Information

  • Mundra and Mumbai
  • Cash in Advance (CID), Cash Advance (CA),
  • 100 , , Box Per Day
  • 3-30 Days
  • Yes
  • Sample costs shipping and taxes has to be paid by the buyer,
  • Box, Carton
  • Australia, Western Europe, Africa, Central America, Middle East, South America, Asia, Eastern Europe, North America,
  • All India,

Product Description

We are providing AXE-250 Tablets, which contains cefuroxime Axetil 250 mg.Effective against a wide variety of organisms including staphylococcus aures, streptococcus pneumoniae.Stable to beta-lactamase hydrolysis.Achieves superior cure rates compared to Penicillin in tonsillopharyngitis.IndicationsSkin & soft Tissue InfectionBone & Joint InfectionUrinary Tract Infections Ent InfectionsPost Operative InfectionTyphoid Fever

FAQs of Axe-250 Tablets (Cefuroxime Axetil Tablets IP 250 MG):


Q: What is the recommended dosage of Axe-250 Tablets?

A: The recommended dosage of Axe-250 Tablets is 250mg, as per the provided guidelines.

Q: What is the storage instruction for Axe-250 Tablets?

A: Axe-250 Tablets should be stored in a dry place.

Q: What type of medication is Axe-250 Tablets?

A: Axe-250 Tablets fall under the category of General Drugs in tablet form.

Q: For whom are Axe-250 Tablets intended?

A: Axe-250 Tablets are intended for adults.

Q: What is the application of Axe-250 Tablets?

A: Axe-250 Tablets are used to treat bacterial infections.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Antibiotic Medicines' category



trade india member
SCHWITZ BIOTECH All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.